Form 4: MYGN Chief Legal Officer Disposes Shares for Tax

Myriad Genetics' Chief Legal Officer, Jennifer Lynne Fox, disposed of 4,435 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Jennifer Lynne Fox, Chief Legal Officer of Myriad Genetics Inc. (MYGN), reported a transaction involving company common stock.
• On September 3, 2025, Ms. Fox disposed of 4,435 shares of common stock.
• This disposition was categorized as an 'F' transaction code, indicating shares withheld by the company to satisfy tax withholding obligations.
• The shares were withheld in connection with the vesting of restricted stock units (RSUs) granted to Ms. Fox.
• The value used for the shares withheld was $6.8 per share, based on the closing price of Myriad common stock on September 3, 2025.
• Following this transaction, Ms. Fox beneficially owns 120,481 shares of Myriad Genetics common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to executive compensation (tax withholding upon RSU vesting), which is neutral in terms of company-specific sentiment.

Positives

• The transaction indicates the vesting of restricted stock units, a common form of executive compensation, which can be seen as a positive for employee retention and motivation.
• The disposition was for tax withholding purposes, a routine and expected event, rather than a discretionary sale, suggesting no negative sentiment from the insider regarding the company's future prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transaction is a routine event and is unlikely to have a significant direct impact on existing shareholders.
• Employees: The vesting of RSUs and subsequent tax withholding is a standard component of executive compensation, reflecting the company's compensation structure.

Key Dates

Recommendation

The Form 4 filing details a routine tax-related disposition of shares by a Chief Legal Officer following the vesting of restricted stock units. This is a standard compensation event and does not reflect a discretionary sale or provide new insights into the company's operational or financial performance, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

MYRIAD GENETICS, MYGN, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Restricted Stock Units, Executive Compensation